How many insider declarations has Savitz Adam filed?

Savitz Adam has filed 2 public insider declarations with SEC (Form 4).

What is Savitz Adam's role?

Savitz Adam's reported role is not specified by the regulator across the filings.

Which companies does Savitz Adam report trades for?

Savitz Adam reports trades for Alto Neuroscience, Inc..

What is Savitz Adam's declared buy vs sell volume?

Across the available history, declared buys total 124k€ and disposals 0.

← Executives ★ Sign in to follow

SA

Savitz Adam

OFFICER

·SEC (Form 4)

Alto Neuroscience, Inc.

0

申报总数

0

公司

€123,750

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-9.7%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Savitz Adam. Officer active across 1 company, notably Alto Neuroscience, Inc.. Cumulatively, 2 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €124k. History available since 9 July 2024. The latest transaction was disclosed on 9 July 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Savitz Adam

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Alto Neuroscience, Inc. (US)

申报2 总计

▲

Savitz Adam

CHIEF MEDICAL OFFICER高管2024年7月9日Alto Neuroscience, Inc.

US$133,83323SEC ↗

10,681 股@ US$12.53100.0% 占其流量Common StockSEC:0001415889-24-019488:0

标准退出：2024年10月7日 (T+90)

●

Savitz Adam

CHIEF MEDICAL OFFICER高管2024年2月6日Alto Neuroscience, Inc.

0SEC ↗

7,851 股Common StockSEC:0001415889-24-002936:0

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

SA

Savitz Adam

OFFICER

·SEC (Form 4)

Alto Neuroscience, Inc.

0

申报总数

0

公司

€123,750

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-9.7%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Savitz Adam. Officer active across 1 company, notably Alto Neuroscience, Inc.. Cumulatively, 2 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €124k. History available since 9 July 2024. The latest transaction was disclosed on 9 July 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.